BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15214904)

  • 1. Variation in calibration of hand-held ultraviolet (UV) meters for psoralen plus UVA and narrow-band UVB phototherapy.
    Lloyd JJ
    Br J Dermatol; 2004 Jun; 150(6):1162-6. PubMed ID: 15214904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet A dosimetry in photopatch test centres in Europe.
    Moseley H
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):187-90. PubMed ID: 15752288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.
    Otman SG; Edwards C; Gambles B; Anstey AV
    Br J Dermatol; 2006 Aug; 155(2):416-21. PubMed ID: 16882183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of acute adverse events for narrow-band UVB and Psoralen-UVA phototherapy.
    Martin JA; Laube S; Edwards C; Gambles B; Anstey AV
    Photodermatol Photoimmunol Photomed; 2007; 23(2-3):68-72. PubMed ID: 17523927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
    Kilinc Karaarslan I; Teban L; Dawid M; Tanew A; Kittler H
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):526-31. PubMed ID: 17373982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traceable calibration of ultraviolet meters used with broadband, extended sources.
    Coleman AJ; Collins M; Saunders JE
    Phys Med Biol; 2000 Jan; 45(1):185-96. PubMed ID: 10661591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy.
    Otman SG; Edwards C; Pearse AD; Gambles BJ; Anstey AV
    Br J Dermatol; 2006 May; 154(5):963-8. PubMed ID: 16634902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midsummer solar UV-radiation in Finland compared with the UV-radiation from phototherapeutic devices measured by different techniques.
    Kolari PJ; Lauharanta J; Hoikkala M
    Photodermatol; 1986 Dec; 3(6):340-5. PubMed ID: 3588354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance and quality control methodologies used within the Austrian UV monitoring network.
    Mario B
    Radiat Prot Dosimetry; 2004; 111(4):359-62. PubMed ID: 15550702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UVA/UVB phototherapy for atopic dermatitis revisited.
    Valkova S; Velkova A
    J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
    Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
    Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [UV irradiation devices for the treatment of psoriasis. Desirable spectra and various criteria for selection].
    Wiskemann A
    Z Hautkr; 1984 Apr; 59(7):449-54. PubMed ID: 6730609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit of the use of psoralen photochemotherapy (PUVA) and narrowband UVB phototherapy in the treatment of psoriasis.
    Yones SS; Palmer RA; Kuno Y; Hawk JL
    J Dermatolog Treat; 2005 Apr; 16(2):108-12. PubMed ID: 16019625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye protection for ultraviolet B phototherapy and psoralen ultraviolet A patients.
    Otman SG; El-Dars LD; Edwards C; Ansari E; Taylor D; Gambles B; Chalmers I; Anstey AV
    Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):143-50. PubMed ID: 20584253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UVB phototherapy and skin cancer risk: a review of the literature.
    Lee E; Koo J; Berger T
    Int J Dermatol; 2005 May; 44(5):355-60. PubMed ID: 15869531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation from ultraviolet phototherapy sources results in photodegradation of 12(R) and 12(S)-hydroxy-eicosatetraenoic acid: high-performance liquid chromatography and polymorph migration studies.
    Amorim I; Green C; Hill A; MacLeod TM; Ferguson J
    Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):214-9. PubMed ID: 1342191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New and established indications for phototherapy with narrowband UVB].
    Berneburg M; Brod C; Benedix F; Röcken M
    J Dtsch Dermatol Ges; 2005 Nov; 3(11):874-82. PubMed ID: 16232274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of tanning induced by narrow-band UVB phototherapy in Korean psoriasis patients.
    Jo SJ; Yoon HS; Woo SM; Youn JI
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):193-9. PubMed ID: 16869868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and accuracy of a newly developed hand-held device with a flat-type fluorescent lamp for measuring the minimal erythema dose for narrow-band UVB therapy.
    Morita A; Shintani Y; Nishida E; Kato H; Yoshida H; Minamoto M; Yamaguchi Y; Maeda A
    Photodermatol Photoimmunol Photomed; 2009 Feb; 25(1):41-4. PubMed ID: 19152515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.